Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

90% e-pharmacy websites in India provides option to upload prescriptions: Study

96% of Online Pharmacies Operating Illegally, Reveals Report

Farhat Nasim9 Jan 2025 4:05 PM IST

New Delhi: The alarming rise of illicit online pharmacies continues to put public health at significant risk, with 96% of online pharmacies operating...

Panel Pushes for Inclusion of Life-Saving Drugs like Benzylpenicillin, Streptomycin in Jan Aushadhi Scheme to Fill Critical Gaps

Farhat Nasim9 Jan 2025 4:04 PM IST

New Delhi: The Jan Aushadhi Scheme, a crucial initiative under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), has made significant...

Senores Pharma buys USFDA approved migraine tablet from Wockhardt

In a First, Rs 32 Crore Drug Testing Lab to Boost Quality Control in Baddi, Himachal

Farhat Nasim9 Jan 2025 2:52 PM IST

Baddi: Himachal Pradesh has opened its first drug testing laboratory in Baddi, bringing much-needed relief to the state's pharmaceutical sector. Built...

Irresponsible Decision: AIOCD Slams Railway Ministry's Plan to Partner with Online Pharmacies

Farhat Nasim8 Jan 2025 4:03 PM IST

New Delhi: Disappointed to know that RailTel Corporation of India has proposed to invite bids from illegal online pharmacy platforms to deliver...

Doctor Takes To LinkedIn To Slam Pricing of Shelcal

Indian Pharma Market Reached Rs 2,21,425 Crore in 2024: PharmaTrac

Farhat Nasim8 Jan 2025 3:59 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) witnessed significant progress in December 2024, registering a 7.7% growth in value and a 1.1%...

Health Ministry Invites Applications for Senior Roles in CDSCO

Farhat Nasim7 Jan 2025 6:55 PM IST

New Delhi: The Ministry of Health and Family Welfare (MoHFW) has invited applications to fill 14 senior-level positions in the Medical Devices...

Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days

CDSCO, ICMR Release Draft IVD Protocols for Arboviral Diagnostics, Seek Feedback

Farhat Nasim6 Jan 2025 2:25 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) and the Indian Council of Medical Research (ICMR) have jointly released draft...

Parliamentary Panel Questions Rejection of NIMERs Proposal, Demands Explanation

Farhat Nasim6 Jan 2025 2:24 PM IST

New Delhi: A Parliamentary panel has expressed its concern over the Department of Expenditure's (DoE) decision to reject the Department of...

Health Ministry Invites Application For Deputy Director at CDSCOs CDTL Mumbai, Salary Up to Rs 2.09 L

CDSCO Moves Clinical Trial Site Addition, PI Change Applications to Online Platform

Farhat Nasim2 Jan 2025 2:08 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has announced a streamlined...

Around 3000 Himachal Doctors Failed to Renew License to Practice

Breather for D.Pharm Graduates: PCI Grants One-Year Provisional Licenses Amid Exit Exam Delays

Farhat Nasim2 Jan 2025 12:59 PM IST

Nagpur: The Pharmacy Council of India (PCI) has come to the aid of Diploma in Pharmacy (D.Pharm) students from the 2022-2023 batch by permitting...

Batch of Telma AM earlier classified as NSQ now flagged as Spurious

CDSCO Flags PAN-40, AUGMENTIN Batches as Spurious in November 2024 Alert

Farhat Nasim1 Jan 2025 2:22 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has declared certain batches of Pantoprazole Gastro-Resistant Tablets I.P....

NPPA to Re-Examine Iohexol Injection Price Challenged by JB Chemicals

Farhat Nasim31 Dec 2024 6:47 PM IST

New Delhi: In a respite to Mumbai-based JB Chemicals and Pharmaceuticals, the Department of Pharmaceuticals (DoP) has directed the National...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok